Westpac Banking Corp’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,060
| Closed | -$64.1K | – | 483 |
|
|
2025
Q1 | $64.1K | Hold |
2,060
| – | – | ﹤0.01% | 429 |
|
|
2024
Q4 | $52.6K | Buy |
+2,060
| New | +$52.6K | ﹤0.01% | 454 |
|
|
2023
Q4 | – | Sell |
-2,891
| Closed | -$78.5K | – | 508 |
|
|
2023
Q3 | $78.5K | Buy |
+2,891
| New | +$78.5K | 0.01% | 452 |
|
|
2023
Q2 | – | Sell |
-26,612
| Closed | -$959K | – | 725 |
|
|
2023
Q1 | $959K | Hold |
26,612
| – | – | 0.01% | 652 |
|
|
2022
Q4 | $1.05M | Hold |
26,612
| – | – | 0.02% | 611 |
|
|
2022
Q3 | $1.07M | Buy |
26,612
+9,320
| +54% | +$374K | 0.02% | 611 |
|
|
2022
Q2 | $727K | Sell |
17,292
-1,471
| -8% | -$61.8K | 0.01% | 712 |
|
|
2022
Q1 | $731K | Sell |
18,763
-10,719
| -36% | -$418K | 0.01% | 735 |
|
|
2021
Q4 | $1.17M | Sell |
29,482
-252
| -0.8% | -$10K | 0.01% | 667 |
|
|
2021
Q3 | $1.07M | Buy |
29,734
+10,242
| +53% | +$370K | 0.01% | 713 |
|
|
2021
Q2 | $799K | Buy |
+19,492
| New | +$799K | 0.01% | 782 |
|
|
2021
Q1 | – | Sell |
-17,292
| Closed | -$865K | – | 839 |
|
|
2020
Q4 | $865K | Buy |
+17,292
| New | +$865K | 0.01% | 752 |
|